Surgery Partners
(NASDAQ) SGRY
Surgery Partners Financials at a Glance
Market Cap
$2.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$3.34B
Net Income (TTM)
-$76.10M
EPS (TTM)
-$0.60
P/E Ratio
-28.96
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$17.02
Volume
1,144,826
Open
$17.27
Price
$17.02
Volume
1,144,826
Open
$17.27
Previous Close
$17.00
Daily Range
$16.99 - $17.44
52-Week Range
$11.41 - $24.10
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$17.02
Volume
1,144,826
Open
$17.27
Previous Close
$17.00
Daily Range
$16.99 - $17.44
52-Week Range
$11.41 - $24.10
Estimated Earnings Date
Aug 4, 2026
SGRY News
SGRY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Surgery Partners
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
16,000
CEO
J. Eric Evans, MBA
Website
www.surgerypartners.comHeadquarters
Brentwood, TN 37027, US
SGRY Financials
Key Financial Metrics (TTM)
Gross Margin
21.68%
Operating Margin
12.26%
Net Income Margin
-2.28%
Return on Equity
-4.43%
Return on Capital
6.79%
Return on Assets
-0.95%
Earnings Yield
-3.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
130.79M
Volume
1.14M
Avg. Volume
1.39M
Financials (TTM)
Gross Profit
$724.80M
Operating Income
$410.00M
EBITDA
$958.20M
Operating Cash Flow
$280.00M
Capital Expenditure
-$72.00M
Free Cash Flow
$208.00M
Cash & ST Invst.
$182.30M
Total Debt
$4.03B
Surgery Partners Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$810.90M
+4.5%
Gross Profit
$121.70M
-24.8%
Gross Margin
15.01%
N/A
Market Cap
$2.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$150.23K
N/A
Employees
15,000
N/A
Net Income
-$35.90M
+4.8%
EBITDA
$105.70M
+7.6%
Quarterly Fundamentals
Total Cash
$182.30M
-20.5%
Total Debt
$4.03B
+3.9%
Accounts Receivable
$603.40M
+5.7%
Inventory
$100.50M
+14.1%
Long Term Debt
$3.89B
+4.1%
Short Term Debt
$142.60M
-0.6%
Return on Assets
-0.95%
N/A
Return on Invested Capital
5.50%
N/A
Free Cash Flow
-$4.30M
+74.3%
Operating Cash Flow
$11.70M
+95.0%